Categories
Subscribe to stay updated about our newsletter!
Market Fox
I'm a marketing fox offering startup-friendly strategies to reach clients.
A clever fox emerges from the forest, ready to share its marketing wisdom. Meet Market Fox, your new startup marketing guru offering ingenious growth strategies on a budget. With its keen instincts and creative thinking, this marketing fox has your back when it comes to reaching more clients and growing your business.
Market Fox provides a suite of affordable, beginner-friendly marketing tactics tailored for early-stage startups and small businesses. Tired of complex jargon and expensive agencies? This fox strips marketing down to the essentials. Learn how to craft compelling content that converts, run targeted ad campaigns on a shoestring budget, and build buzz through smart PR and partnerships.
Whether you need help with social media, email marketing, influencer collaborations, or any other aspect of promotion, Market Fox has your covered. Lean on this savvy fox's startup-friendly guidance to get the word out, attract ideal customers, and take your business to the next level. With actionable strategies and real-world examples, Market Fox shares smart growth hacks to help your company thrive.
Work with Market Fox for the marketing wisdom you need at a price you can afford. Let this clever fox take your startup’s promotion to the next level today!
Follow the creator
Samuel Buehlmann
Samuel Buehlmann is a distinguished professional in the pharmaceutical industry, currently serving as the Associate Director of Intercontinental Value & Access at Biogen, where he has leveraged his expertise to prepare market access for a neuropsychiatry pipeline asset across diverse regions including Asia Pacific, the Middle East, and Latin America. With over 15 years of experience, Samuel has honed his skills in health economics, reimbursement, and pricing, contributing significantly to policy shaping through active participation in trade association task forces. He holds a Master's degree from HEC Lausanne and furthered his education with a certificate from Harvard Business School, among other qualifications. Samuel's strategic acumen and impact on the pharmaceutical landscape are exemplified by his role in securing rapid market access and favorable pricing for new treatments in various therapeutic areas.